0001493152-26-015512
SEC filingAimei Health Technology Co., Ltd extended its business combination deadline to May 6, 2026, by depositing $34,330.96 into its trust account, funded via an unsecured promissory note issued to its Sponsor and United Hydrogen Group Inc.
Aimei Health Technology Co., Ltd utilized the seventeenth extension permitted under its Amended and Restated Articles of Association to extend the deadline for consummating an initial business combination. The extension moves the Termination Date from April 6, 2026, to May 6, 2026. To satisfy the requirement for this extension, the Company deposited $34,330.96 into its trust account, representing the lesser of $80,000 for all outstanding public shares or $0.033 per share for the monthly extension. This payment was funded through the issuance of an unsecured promissory note to Aimei Health Ltd (the Sponsor) and United Hydrogen Group Inc., rather than using existing corporate funds. The note is structured with no interest and includes a conversion feature allowing the Payees to convert the principal into private units at $10.00 per unit prior to the closing of the Business Combination with United Hydrogen. This transaction indicates the Company is continuing its efforts to complete the proposed business combination with United Hydrogen but requires additional time and sponsor financing to do so.